| Literature DB >> 27292636 |
Huacheng Luo1, Anitha K Shenoy1, Xuehui Li2, Yue Jin1, Lihua Jin3, Qingsong Cai1, Ming Tang1, Yang Liu1, Hao Chen1, David Reisman4, Lizi Wu5, Edward Seto6, Yi Qiu2, Yali Dou7, Robert A Casero3, Jianrong Lu8.
Abstract
The histone demethylase LSD1 facilitates epithelial-to-mesenchymal transition (EMT) and tumor progression by repressing epithelial marker expression. However, little is known about how its function may be modulated. Here, we report that LSD1 is acetylated in epithelial but not mesenchymal cells. Acetylation of LSD1 reduces its association with nucleosomes, thus increasing histone H3K4 methylation at its target genes and activating transcription. The MOF acetyltransferase interacts with LSD1 and is responsible for its acetylation. MOF is preferentially expressed in epithelial cells and is downregulated by EMT-inducing signals. Expression of exogenous MOF impedes LSD1 binding to epithelial gene promoters and histone demethylation, thereby suppressing EMT and tumor invasion. Conversely, MOF depletion enhances EMT and tumor metastasis. In human cancer, high MOF expression correlates with epithelial markers and a favorable prognosis. These findings provide insight into the regulation of LSD1 and EMT and identify MOF as a critical suppressor of EMT and tumor progression.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27292636 DOI: 10.1016/j.celrep.2016.05.050
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423